U.S. Professional Services Stock News

NYSE:AMR
NYSE:AMRMetals and Mining

Is Alpha’s Rare Quarterly Loss and Ongoing Buybacks Altering The Investment Case For Alpha Metallurgical Resources (AMR)?

Alpha Metallurgical Resources recently issued preliminary unaudited guidance indicating it expects to report a net loss of US$17.3 million, or US$1.34 per diluted share, for the fourth quarter of 2025, and confirmed it has repurchased 113,000 shares for US$20 million in the final quarter of 2025. This update highlights a rare quarterly loss for a company that has emphasized conservative capital allocation and has retired over 43% of its shares since March 2022. We’ll examine how the...
NYSE:BLDR
NYSE:BLDRBuilding

Is Builders FirstSource (BLDR) Still Attractive After A Mixed Year Of Share Price Moves

If you are wondering whether Builders FirstSource at around US$118 still offers solid value, or if most of the opportunity is already priced in, this article is designed to help you assess that for yourself. The stock has a 7 day return of 1.1%, a 30 day and year to date return of 13.3%, but a 1 year return showing a 27.5% decline, so recent moves look very different depending on the time frame you focus on. Recent market attention has been shaped by ongoing interest in US housing and...
NYSE:MAS
NYSE:MASBuilding

A Look At Masco (MAS) Valuation After A Weak Q3 And Challenging Market Commentary

Q3 earnings miss and market reaction Masco (MAS) reported a disappointing Q3, with revenue down 3.3% year on year and adjusted operating income and EBITDA below analyst expectations, with management pointing to challenging market conditions as a key headwind. See our latest analysis for Masco. Despite the weak Q3, Masco’s share price has shown positive short term momentum, with a 30 day share price return of 5.55% and a 3 year total shareholder return of 31.90%, although the 1 year total...
NYSE:RITM
NYSE:RITMMortgage REITs

Rithm Capital (RITM) TTM Earnings Surge 60.5% Tests Bearish Cash Flow Narratives

Rithm Capital (RITM) has put up a steady run of numbers heading into FY 2025, with third quarter revenue at US$943 million and basic EPS of US$0.36, alongside trailing twelve month revenue of about US$4.0 billion and EPS of US$1.47. The company has seen quarterly revenue move between US$646 million and US$1.3 billion over the last six reported periods, with basic EPS ranging from US$0.07 to US$0.54. This sets a clear backdrop for how investors might read the current US$10.95 share price...
NasdaqGS:AVGO
NasdaqGS:AVGOSemiconductor

Is It Too Late To Consider Broadcom (AVGO) After A 7x Five Year Run?

Some investors may be wondering if Broadcom's share price still offers value after a large multi year run, or if most of the upside is already reflected in the stock. The shares closed at US$320.33, with a 3.7% decline over the last 7 days and a 7.9% decline over the last 30 days. Over the last 1 year the return sits at 45.3%, and the 5 year return is around 7x. Recent news coverage has focused on Broadcom's role as a major semiconductor and infrastructure software player and how that...
NYSE:RES
NYSE:RESEnergy Services

RPC (RES) Margin Compression Challenges Bullish Narratives Despite FY 2025 Q3 Revenue Scale

RPC (RES) has just posted its FY 2025 third quarter scorecard, reporting revenue of $447.1 million and basic EPS of $0.06. This puts fresh numbers on the table after a run of mixed earnings over the past year. The company’s revenue has moved from $364.2 million in FY 2024 Q2 to $337.7 million in Q3 and $335.4 million in Q4, then to $332.9 million, $420.8 million and now $447.1 million through FY 2025. Over the same stretch, quarterly EPS shifted from $0.15 to $0.09, $0.06, $0.06, $0.05 and...
NYSE:WAT
NYSE:WATLife Sciences

Waters Reshapes Growth Path With Wyatt Deal And BD Biosciences Merger

Waters Corporation (NYSE:WAT) has completed its acquisition of Wyatt Technology as part of a broader shift in its business strategy. The company has also announced a planned merger with BD Biosciences, signaling a push deeper into large molecule applications. These moves are expected to reshape Waters' role in the biotech and life sciences tools space, with implications for its future operations. Waters, trading at $378.95, is responding to a period of mixed share performance with an active...
NasdaqGS:NWL
NasdaqGS:NWLConsumer Durables

Is Newell Brands (NWL) Still Mispriced After Recent Share Price Rebound?

If you are wondering whether Newell Brands' current share price reflects its true worth, you are not alone. This article walks through what the latest data says about value. The stock most recently closed at US$4.40, with returns of 0.9% over 7 days and 18.3% over both the last 30 days and year to date, against a longer term record that includes a 52.0% decline over 1 year, 67.4% over 3 years and 79.4% over 5 years. Those mixed returns sit against a backdrop of ongoing attention on Newell...
NasdaqGS:TWST
NasdaqGS:TWSTBiotechs

Twist Bioscience Raises Outlook As AI DNA Demand Builds Profit Focus

Twist Bioscience (NasdaqGS:TWST) reported its twelfth consecutive quarter of revenue growth. The company raised its full year outlook, citing momentum in AI enabled DNA synthesis and wider use of its platform. Management also reiterated a focus on progressing toward profitability alongside scaling the business. Twist Bioscience, a provider of synthetic DNA and related tools, operates at the intersection of biotechnology and AI driven research. Its platform supports customers in areas such...
NYSE:GKOS
NYSE:GKOSMedical Equipment

How FDA Approval of Repeat iDose TR Use Will Impact Glaukos (GKOS) Investors

In late January 2026, Glaukos Corporation received FDA approval for an NDA labeling supplement that permits repeat administration of its long-duration iDose TR glaucoma implant, supported by clinical data showing safe and well-tolerated second treatments over 12 months. This decision effectively positions iDose TR as a potentially longer-term, repeatable treatment option aimed at reducing non-compliance and side effects linked to traditional eye-drop therapies for glaucoma. Next, we will...
NYSE:LION
NYSE:LIONEntertainment

Assessing Lionsgate Studios (LION) Valuation After Recent Share Price Volatility

Why Lionsgate Studios Stock Is Drawing Attention Now Lionsgate Studios (LION) has caught investor attention after recent trading left the share price at US$8.98, with returns ranging from a 3.4% decline over the month to a 33.2% gain in the past 3 months. See our latest analysis for Lionsgate Studios. Recent trading has been choppy, with a 1-day share price return of 2.7% decline and a 7-day share price return of 6.2% decline. However, the 90-day share price return of 33.2% suggests momentum...
NasdaqGS:EWBC
NasdaqGS:EWBCBanks

East West Bancorp Dividend Hike Highlights Earnings Strength And Payout Capacity

East West Bancorp (NasdaqGS:EWBC) announced a 33% increase in its quarterly dividend. The higher dividend follows the company’s latest annual and quarterly results, which management described as strong. The move signals an increased cash return to shareholders through the regular dividend. East West Bancorp is a commercially focused bank with a footprint that connects U.S. and Asia linked clients, serving businesses and individuals across a range of lending and deposit services. For...
NasdaqGS:CRVL
NasdaqGS:CRVLHealthcare

CorVel (CRVL) Earnings Growth And 11.3% Margin Challenge Cautious Narratives

CorVel (CRVL) has just wrapped up Q3 2026 with its recent numbers anchored by the latest reported quarter, where revenue in Q2 2026 was US$239.6 million and basic EPS came in at US$0.54. This feeds into trailing 12 month EPS of US$2.05 and net income of US$105.3 million. Over the recent reporting periods, the company has seen revenue move from US$224.4 million in Q2 2025 to US$239.6 million in Q2 2026, with basic EPS stepping from US$0.46 to US$0.54 over the same quarters. This sets up a...
NYSE:GLW
NYSE:GLWElectronic

Corning Ties Meta Fiber Deal And Project Vault To Rich Valuation

Corning (NYSE:GLW) has signed a multiyear agreement to supply Meta Platforms with advanced optical fiber and cable for AI data centers. The company is investing in expanded manufacturing capacity to support this contract. Corning is also participating in the US federal Project Vault initiative for critical minerals stockpiling. Corning, trading at $112.79, has seen very strong recent share price performance, with the stock up 24.4% over the past month and 120.9% over the past year. Returns...
NasdaqGS:CSWC
NasdaqGS:CSWCCapital Markets

Capital Southwest (CSWC) Earnings Growth And 45.2% Margin Challenge Cautious Narratives

Capital Southwest (CSWC) just posted Q3 2026 results with total revenue of US$61.4 million and basic EPS of US$0.57, setting the tone for another data rich update on its earnings power. The company has seen quarterly revenue move from US$51.9 million in Q3 2025 to US$61.4 million in Q3 2026, while basic EPS shifted from US$0.34 to US$0.57 over the same period. This gives investors a clear sense of how the top and bottom lines have trended into this quarter. With a trailing 12 month net profit...
NYSE:YOU
NYSE:YOUSoftware

Is Clear Secure’s (YOU) High-Margin Growth Evidence of Durable Operating Leverage or Early-Stage Luck?

CLEAR Secure recently reported that its biometric identity verification business has delivered 23.2% annual revenue growth over the last two years, while maintaining disciplined cost controls that produced a trailing 12‑month operating margin of 19.2%. This combination of rapid top-line expansion and efficient use of fixed costs highlights how the company is scaling its airport and venue network without proportionately increasing expenses. Next, we will examine how Clear Secure's strong cost...
NYSEAM:TCGL
NYSEAM:TCGLIT

TechCreate Group (TCGL) Valuation Check After Speculation Fueled Share Price Spike And Volatility Halts

Speculative surge puts TechCreate Group (TCGL) in the spotlight TechCreate Group (TCGL) has been thrust into the market spotlight after a very large short term share price spike, including volatility halts, largely linked to speculative trading and momentum driven sentiment. See our latest analysis for TechCreate Group. With TechCreate Group’s share price now at $172.84 after a 1 day share price return of around 100% and a very large 30 day gain, the move caps a powerful short term run that...
NasdaqGS:FIGR
NasdaqGS:FIGRConsumer Finance

Assessing Figure Technology Solutions (FIGR) Valuation After A Sharp Short-Term Share Price Pullback

Event context and recent share performance Figure Technology Solutions (FIGR) has drawn fresh attention after recent trading left the stock down about 15% over the past day and roughly 29% over the past week, despite modest gains over the past month and past 3 months. See our latest analysis for Figure Technology Solutions. The sharp 1-day and 7-day share price returns, down 14.85% and 29.05% respectively, contrast with a 15.14% 3-month share price return and a positive year to date share...
NasdaqGS:AMZN
NasdaqGS:AMZNMultiline Retail

How Investors Are Reacting To Amazon.com (AMZN) Job Cuts And Massive AI Investments

In recent days, Amazon has moved to cut about 16,000 corporate roles, confirmed plans for a further 2,200 job reductions in Washington state starting April 28, and continued to highlight artificial intelligence as a core focus across AWS, logistics, and broader operations ahead of its February 5 earnings release. What stands out is how Amazon is pairing aggressive cost-cutting with deeper AI ties, including preliminary talks to invest up to US$50.00 billion in OpenAI and a US$38.00 billion...
NasdaqGM:VERA
NasdaqGM:VERABiotechs

Is Vera’s New Commercial Chief for Atacicept Reshaping the Investment Case for Vera Therapeutics (VERA)?

Vera Therapeutics recently appointed Matt Skelton as Chief Commercial Officer, effective January 28, 2026, elevating him from his prior role as Executive Vice President, Commercial to lead preparations around the potential launch of its lead drug candidate, atacicept, for IgA nephropathy. His background in building commercial organizations and guiding multiple drug launches at Seagen, Amgen, and Eli Lilly highlights Vera’s emphasis on experienced leadership as it moves toward possible...
NYSE:PNC
NYSE:PNCBanks

Is PNC Financial (PNC) Pricing Reflect Recent Gains And Regulatory Focus On Big Banks

If you are wondering whether PNC Financial Services Group is priced attractively right now, it helps to start with how the market has been treating the stock recently and what that might say about value. PNC Financial Services Group last closed at US$233.82, with returns of 4.5% over 7 days, 10.6% over 30 days, 10.6% year to date, 21.8% over 1 year, 61.8% over 3 years, and 77.2% over 5 years. This gives important context before weighing up what you are paying versus what you may be...
NYSE:EPD
NYSE:EPDOil and Gas

Enterprise Products Partners Q3 Net Margin Improvement Tests Income Bear Narratives

Enterprise Products Partners (EPD) has laid out a steady set of numbers for FY 2025 so far, with third quarter revenue at US$12.0 billion and basic EPS of US$0.61, alongside trailing 12 month revenue of US$53.0 billion and basic EPS of US$2.65 that frame the latest print in a broader context. The partnership has seen quarterly revenue move from US$13.8 billion in the third quarter of 2024 to US$12.0 billion in the third quarter of 2025, while basic EPS shifted from US$0.65 to US$0.61 over the...
NasdaqGS:CRWV
NasdaqGS:CRWVIT

Assessing CoreWeave (CRWV) Valuation After Recent Share Price Volatility

CoreWeave overview and recent performance snapshot CoreWeave (CRWV) has drawn fresh attention after recent trading swings, with the stock last closing at US$90.06. Short term returns are mixed, including a 1 day gain alongside a 7 day decline. See our latest analysis for CoreWeave. For context, CoreWeave’s recent moves include a 13.54% 1 month share price return alongside a 21.29% 3 month share price decline, so current momentum looks more like a reset than a steady uptrend. If CoreWeave’s...
NYSE:MUR
NYSE:MUROil and Gas

What Murphy Oil (MUR)'s Weaker Earnings, Higher Dividend and New 2026 Outlook Mean For Shareholders

In January 2026, Murphy Oil Corporation reported fourth-quarter 2025 revenue of US$624.56 million and net income of US$11.89 million, alongside full-year revenue of US$2.72 billion and net income of US$104.23 million, both lower than the prior year despite steady production levels. At the same time, Murphy Oil raised its quarterly dividend to US$0.35 per share, issued US$500.00 million of 6.500% notes due 2034 to refinance existing debt, and outlined 2026 production guidance that gives...